These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29505187)

  • 1. Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs.
    Manning JS
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.
    Dilks S; Xavier RM; Kelly C; Johnson J
    Nurs Clin North Am; 2019 Dec; 54(4):595-608. PubMed ID: 31703784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal-Emergent Dyskinesia Following Abrupt Discontinuation of Desvenlafaxine.
    Wu L; Gerdts EA; Alam A
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30664338
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
    Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Patients for Tardive Dyskinesia.
    Kane JM
    J Clin Psychiatry; 2017; 78(9):e1428. PubMed ID: 29345876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools.
    Saklad SR
    J Clin Psychiatry; 2020 Jan; 81(1):. PubMed ID: 31944066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier Diagnosis of Tardive Dyskinesia.
    Kremens DE
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31846242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laughter therapy in a geriatric patient with treatment-resistant depression and comorbid tardive dyskinesia.
    Pan PY; Yeh CB
    Aust N Z J Psychiatry; 2016 Dec; 50(12):1206-1207. PubMed ID: 27164922
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive Dyskinesia Should Not Be Overlooked.
    Kakko K; Bjelogrlic-Laakso N; Pihlakoski L; Lehtimäki K; Järventausta K
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):72-74. PubMed ID: 30388034
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tardive dyskinesia in a child treated with atypical antipsychotics].
    Wittevrongel E; Vranken E; Pepermans A; Jaspers T
    Tijdschr Psychiatr; 2020; 62(10):901-905. PubMed ID: 33184822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment.
    Correll CU; Kane JM; Citrome LL
    J Clin Psychiatry; 2017; 78(8):1136-1147. PubMed ID: 29022654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive syndrome: An update and mini-review from the perspective of phenomenology.
    Chen CY; Chiang HL; Fuh JL
    J Chin Med Assoc; 2020 Dec; 83(12):1059-1065. PubMed ID: 32956105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
    Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
    Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive Myoclonus Responsive to Clozapine Misdiagnosed as Restless Leg Syndrome: A Case Report.
    Selçuk M
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):692-694. PubMed ID: 34459435
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.
    Caroff SN; Mu F; Ayyagari R; Schilling T; Abler V; Carroll B
    BMC Psychiatry; 2020 Jul; 20(1):365. PubMed ID: 32652964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.